Dissolution and drug release testing

Slides:



Advertisements
Similar presentations
Design and Calibration of a Dissolution Test Equipment Training Workshop on Dissolution, Pharmaceutical Product Interchangeability and Biopharmaceutical.
Advertisements

rational design of drug products
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Bioequivalence of Topical Products
1 Dissolution Measurement System: Current State and Opportunities for Improvement Dr. Lucinda Buhse Director, Division of Pharmaceutical Analysis.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
Methods of tablet manufacturing
Pharmacopoeial tests (USP)
DRUG DOSAGE FORMS Dr.Abdul Latif Mahesar.
Determine impurity level in relevant batches1
OPTIMISING MEDICINES DEVELOPMENT
Solid Dosage Forms (Capsules)
ABSORPTION OF DRUGS DR.SOBAN SADIQ.
World Health Organization
Roselyn Aperocho-Naranjo Pharmacy Instructor USPF, College of Pharmacy
Ion-Exchange Resins as Drug Delivery Carriers Resins used are polymers that contain appropriately substituted acidic groups, such as carboxylic and sulfonic.
Dissolution Lynda Paleshnuik Training workshop: Assessment of Interchangeable Multisource Medicines, Kenya, August 2009.
Quality control of tablets
10/1/20151 BIOPHARMACEUTICS, NEW DRUG DELIVERY SYSTEMS & DEVICES A. S. Adebayo, Ph.D.
OVERVIEW OF DACA BIOEQUIVALENCE REPORT EVALUATION Presented by Solomon Shiferaw 31Augst 2010.
Kh. Sadique Faisal Asst. Lecturer Northern University Bangladesh
Powders and Granules Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics Faculty of Pharmacy Omer Al-Mukhtar University Tobruk, Libya.
PHARMACEUTICS- IV (PHT 414 ) Dr. Shahid Jamil SALMAN BIN ABDUL AZIZ UNIVERSITY COLLEGE OF PHARMACY L /9/2015 Factors Affecting Drug Absorption (Dosage.
Analytical considerations in the dissolution testing of oral modified release products Graham Clarke Bristol-Myers Squibb Moreton, UK The British Pharmaceutical.
Quality control Lecture 1.
Chapter 13. Dissolution Phenomena
Formulation factors By Dr. A. S. Adebayo.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Bioavailability Dr Mohammad Issa.
<701> DISINTEGRATION
The USP Performance Test Dissolution Systems Suitability Studies Walter W. Hauck, Ph.D. USP Consultant Presentation to Advisory Committee for Pharmaceutical.
1 Abu Alam Ph.D. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 23, 2008.
Bioequivalence of Locally Acting Gastrointestinal Drugs: An Overview
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
 1-What is the best drug to be used?  2-How it is going to be given?
Solid dosage forms Tablets
Quality control Lecture 1.
Suppositories – dosage form which are solid at room temperature and melting or dissolving at body temperature are intended for administration in the body.
1/20 PRESENTED BY BRAHMABHATT BANSARI K. M. PHARM DEPARTMENT OF PHARMACEUTICS AND PHARMACEUTICAL TECHNOLGY L. M. COLLEGE OF PHARMACY.
Dissolution Test (U.S.P.): Two set of apparatus: Apparatus-1: A single tablet is placed in a small wire mesh basket attached to the bottom of the shaft.
Drug Forms and Routes of Administration
- Pharmaceutical Equivalence Study
Solid dosage forms Tablets
SEMINAR ON…. In Vitro Dissolution Testing Models
Gastrointestinal Absorption: Role of the Dosage Form
Biopharmaceutics of modified release drug products
Biopharmaceutics factors affecting Modified release products
Quality control of tablets
Biopharmaceutic Considerations in Drug Product Design
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Group members: Firdaus | Sofia | Nurainiza | Hafizah
Factors Affecting Drug Absorption (Dosage form factor)
Disintegration test & Dissolution test (official test)
Quality control Lecture 1.
Quality Control Requirement
Lab -7- Capsules.
PITFALLS TO BEWARE IN IN-VITRO RELEASE STUDIES Presented by: Maneesha Pande Department of Chemical Engineering, Indian Institute of Technology Delhi.
Firdaus | Sofia | Nurainiza | Hafizah
Tablet Dosage Form Lab 1.
Lab -7- Capsules.
Biopharmaceutics 4th year
Micrometrics. It is the science and technology of small particles. Knowledge and control of the size and the size range of particles are of significant.
Biopharmaceuitcs lab 6 In vitro dissolution study of per – oral tablet.
Tablets Lecturer: dr. Asmaa abdelaziz Mohamed Faculty of pharamcay
POWDER AND GRANULES FADHILAH FAIROZA FATIN HUSNA
Evaluation of tablet dosage form 4) Disintegration
Quality control Lecture 1.
Evaluation of tablet dosage form 5) dissolution
RingCap Technology Mrs. Maria Saifee Associate Professor,
Formulation factors By Dr. A. S. Adebayo.
Presentation transcript:

Dissolution and drug release testing Dr Mohammad Issa

Why do we study dissolution? Drug in the blood and the body Disintegration Dissolution Absorption

Dissolution and drug release tests Dissolution and drug release tests are in-vitro tests that measure the rate and extent of dissolution or release of the drug substance from a drug product, usually in an aqueous medium under specified conditions The dissolution test is an important quality control procedure for the drug product and is often linked to product performance in vivo. In-vitro drug dissolution studies are most often used for monitoring drug product stability and manufacturing process

Conditions that May Affect Drug Dissolution and Release: Drug and formulation related Drug substance Particle size   Polymorph   Surface area   Chemical stability in dissolution media Formulation of drug product   Excipients (lubricants, suspending agents, etc)

Conditions that May Affect Drug Dissolution and Release: methodology related Medium   Volume   pH   Molarity   Co-solvents, added enzymes/surfactants Temperature of medium Apparatus Hydrodynamics   Agitation rate   Shape of dissolution vessel   Placement of tablet in vessel   Sinkers (for floating products and products that stick to side of vessel)

Dissolution Apparatus

Dissolution Apparatus Apparatusa   Name Drug Product Apparatus 1 Rotating basket Tablets Apparatus 2 Paddle Tablets, capsules, modified drug products, suspensions Apparatus 3 Reciprocating cylinder Extended-release drug products Apparatus 4 Flow cell Drug products containing low-water-soluble drugs Apparatus 5 Paddle over disk Transdermal drug products Apparatus 6 Cylinder Apparatus 7 Reciprocating disk Rotating bottle (Non-USP-NF) Extended-release drug products (beads) Diffusion cell (Franz) Ointments, creams, transdermal drug products aApparatus 1–7 refer to compendial dissolution apparatus in USP-NF (United States Pharmacopeia)

Rotating basket (Apparatus 1)

Rotating basket (Apparatus 1) In case of none-disintegrating dosage forms this apparatus is superior to apparatus 2 since it constraints the dosage form in a steady state fluid flow It is inferior for testing dosage forms which contains gums due to clogging of screen matrix

Rotating basket (Apparatus 1) In the case of floating dosage forms this method performs well, but care should be taken that excepients do not clog the basket mesh

Rotating Paddle (Apparatus 2)

Rotating Paddle (Apparatus 2) This apparatus is identical to apparatus 1 except that the paddle is substituted for the rotating basket Frequently used for both disintegrating and non-disintegrating dosage forms

Reciprocating cylinder (Apparatus 3)

Reciprocating cylinder (Apparatus 3) One advantage of the reciprocating cylinder is that the gastrointestinal tract conditions can be easily simulated, as it is easy to make time dependent pH changes This apparatus is most suitable for nondisintegrating (extended release) or delayed release (enteric coated) dosage forms

Flow cell (Apparatus 4)

Flow cell (Apparatus 4) The advantage of flow through cell apparatus is the ability to test drugs of very low aqueous solubility and the ability to change the pH conveniently during the test

Paddle over disk (Apparatus 5)

Cylinder (Apparatus 6) The cylinder method (Apparatus 6) for testing transdermal preparation is modified from the basket method (Apparatus 1). In place of the basket, a stainless steel cylinder is used to hold the sample.

Reciprocating Disk Method (Apparatus 7) In the reciprocating disk method for testing transdermal products, a motor drive assembly (Apparatus 7) is used to reciprocate the system vertically, and the samples are placed on disk-shaped holders using cuprophan supports